)
PureTech Health (PRTC) investor relations material
PureTech Health 44th Annual J.P. Morgan Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Business model and strategy
Operates a hub-and-spoke model, spinning out programs into standalone entities to advance therapies and generate financial returns.
Focuses on de-risked drug development by targeting validated pharmacology and high unmet medical needs.
Portfolio approach enables risk balancing and efficient capital allocation, with no bias toward continuing underperforming programs.
Retains equity and non-dilutive economics (royalties, milestones) in spun-out entities, ensuring multiple value streams.
Emphasizes continuous innovation, particularly in small molecules and CNS, leveraging prior success and expertise.
Clinical and financial achievements
Achieved 80% clinical trial success rate and three FDA-approved treatments, including Cobenfy for schizophrenia.
Cobenfy generated over $1.1 billion in gross returns from an $18.5 million investment, with ongoing royalties and milestones valued at ~$300 million through 2033.
Seaport Therapeutics spun out, raising $325 million, with PureTech retaining a 35% stake and non-dilutive economics.
Self-funded for eight years, maintaining a $320 million balance sheet as of 2025 H1.
Pipeline and upcoming milestones
Celea Therapeutics is advancing deupirfenidone, a next-gen antifibrotic for IPF, showing significant efficacy in phase II-B and moving to phase III.
Gallop Oncology is developing LYT-200, a novel antibody for AML, showing median overall survival of 13.2 months in phase I, surpassing benchmarks.
Seaport Therapeutics has three candidates, two in clinical stage for major depressive and generalized anxiety disorders.
Operational priorities for 2026 include securing funding for Gallop and Celea, initiating pivotal trials, and spinning out these programs.
Next PureTech Health earnings date
Next PureTech Health earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)